Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?
- PMID: 34780876
- DOI: 10.1016/j.jhep.2021.11.007
Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?
Keywords: hepatocellular carcinoma; immunotherapy; prognosis.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?".J Hepatol. 2022 Apr;76(4):988-989. doi: 10.1016/j.jhep.2021.12.025. Epub 2021 Dec 31. J Hepatol. 2022. PMID: 34979133 No abstract available.
Comment on
-
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.J Hepatol. 2022 Feb;76(2):353-363. doi: 10.1016/j.jhep.2021.09.035. Epub 2021 Oct 12. J Hepatol. 2022. PMID: 34648895
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical